Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis

Wolf, Erin, Rich, Nicole E., Marrero, Jorge A., Parikh, Neehar D., Singal, Amit G.·2021·Hepatology

Cited by (333)

Items 301–333 of 333

  1. Mining of Targeted Therapeutic Drugs for Hepatocellular Carcinoma based on Programmed Cell Death-related Features and Construction of an Imaging Histology Diagnostic Model
    Juan Wang, Xiaoli Zhao, C.-J. Chen, H.-F. Li, Chunli Liu, Zhongfeng Cui, Guangming Li · 2025 · Current Topics in Medicinal Chemistry
  2. Should a Randomized Controlled Trial of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis Be Performed?
    Ian A.C. Rowe · 2025 · Springer eBooks
  3. Travel Distance and Insurance Status: Association With Treatment Access and Survival Among Patients With Hepatocellular Carcinoma
    Miho Akabane, Abdullah Altaf, Jun Kawashima, Yuki Imaoka, Timothy Michael Pawlik · 2025 · Journal of Surgical Oncology
  4. Present and future of systemic therapy for early and intermediate stages of hepatocellular carcinoma
    Carlos Alventosa Mateu, Juan José Urquijo Ponce · 2025 · Revisiones en cáncer
  5. Underuse of hepatocellular carcinoma surveillance in patients with cirrhosis: a nested cohort study
    Pascal Caillet, Frédéric Balusson, Nathalie Ganne‐Carrié, Emmanuel Oger, Charlotte E. Costentin, O. Ganry · 2025 · medRxiv
  6. Evaluating hepatocellular carcinoma (HCC) surveillance through an early diagnostic centre: An implementation science approach at a tertiary hepatology centre in England
    Hamzah Z. Farooq, Kevin Galono, Leila Reid, Janet Dearden, Graham R. Foster · 2025 · Clinical Medicine
  7. A contemporary review of care gaps in hepatocellular carcinoma surveillance
    Nikki K. Duong, Veronica Nguyen, Mindie H. Nguyen · 2025 · Expert Review of Gastroenterology & Hepatology
  8. Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North Carolina
    Christine D. Hsu, Louise M. Henderson, Bradford E. Jackson, Christopher D. Baggett, Michele Jönsson Funk, Andrew F. Olshan, Parul Gupta, A. Sidney Barritt, Hanna Kelly Sanoff, Stephanie B. Wheeler et al. · 2025 · North Carolina Medical Journal
  9. Diagnostic Performance Comparison of AFP, PIVKA-II, GALAD Model, and ASAP Model Across Two Chemiluminescence Immunoassay Platforms for Hepatocellular Carcinoma
    Yuan Huang, Rui Ding, Yue Cui, Peng Li, Jie Niu, Guan-Hua Wang, Xu-Zhen Qin · 2026 · Journal of Hepatocellular Carcinoma
  10. Special Populations
    Robert J. Wong, Massimo G. Colombo, Elisa Pinto, Patrizia Burra · 2026 · Clinics in Liver Disease
  11. Expert Practical Recommendations for Hepatocellular Carcinoma
    Feng Su, Alejandro Torres-Hernandez, Ryan Hickey, Krishna Shanbhogue, Kristen Renee Spencer, Karim Jarir Halazun, Augusto Villanueva · 2026 · Seminars in Liver Disease
  12. Bedeutung des Multidisziplinären Tumorboards in der Behandlung des hepatozellulären Karzinoms und des cholangiozellulären Karzinoms
    Jörg Lehner, Thomas B. Brunner · 2026 · Die Onkologie
  13. Telehealth in Hepatocellular Carcinoma: Current Use and Future Directions
    Laura Salej Duran, Dabel Emebo, Jeremy Louissaint · 2026 · Current Hepatology Reports
  14. Modality-Specific and Multilevel Barriers to Curative Treatment for Early-Stage Hepatocellular Carcinoma
    Ashwini Arvind, Lisa Quirk, Sneha Deodhar, Samuel Phen, Gi Giamarqo, Emma Jones, Celina Li, Kishore Botla, Christina Zhu, Sanjeeva Kalva et al. · 2026 · Liver Cancer
  15. Scientific, regulatory, and practical considerations for bringing hepatocellular carcinoma biomarkers into clinical practice
    Blanca Botía Martínez-Artero, Eleonora Alimenti, James K. Carter, David James Pinato, Augusto Villanueva · 2026 · JHEP Reports
  16. Pandemic-Related Disruptions and Hepatocellular Carcinoma Surveillance in Safety-Net Settings
    Robert J. Wong, Patricia Jones, Bolin Niu, Paulo Pinheiro, Mae Thamer, Onkar S. Kshirsagar, Y Zhang, Ronnie Fass, Daniela Prieto-Bello, Lisa Quirk et al. · 2026 · JAMA Network Open
  17. Socioeconomic Inequalities in Receipt of Curative‐Intent Treatment and Survival After Surveillance‐Detected Hepatocellular Carcinoma: A Nationwide Cohort Study
    Hannes Hagström, Jeffrey Victor Lazarus, Malin Sternby Eilard, Adam Bergman, Magnus Rizell, Per Sandström, Juan Vaz · 2026 · Alimentary Pharmacology & Therapeutics
  18. Letter to the Editor: Origin recognition complex subunit 1 as a biomarker in hepatitis B virus-related hepatocellular carcinoma: Promises and pitfalls
    Lian-Bang Wang, Xi-Ming Wang, Xin-Ya Zhao, Gong‐Zheng Wang · 2026 · World Journal of Gastroenterology
  19. Global disparities in hepatocellular carcinoma care: insights from the ESGAR Global Abdominal Imaging Forum
    Roberto Cannella, Federica Vernuccio, Cäcilia S. Reiner, Katja N. De Paepe, Giuseppe Brancatelli, Valérie Vilgrain, Marc Zins, Damian Tolan · 2026 · European Radiology
  20. FROM BIOMARKERS TO PRECISION SURVEILLANCE: A SOCIO-TECHNICAL REVIEW OF NON-INVASIVE HEPATOCELLULAR CARCINOMA SCREENING IN CIRRHOSIS
    Kamil Chudzicki, Michał Babicz, Oliwer Muller, Jagoda Pałubska, Katarzyna Rosa, Agata Słoma, Anna Szot, Dominik Szydełko, Martyna Szymczyk, Paweł Żurek · 2026 · International Journal of Innovative Technologies in Social Science
  21. Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations
    Neehar D. Parikh, Chun-Chi Liu, Matthew DeMaio, Angela H. Yeh, Mary L. Stackpole, S Li, Vatche Garen Agopian, Wenyuan Li, Xianghong Jasmine Zhou, Xiaohui Ni et al. · 2026 · Hepatology Communications
  22. A bibliometric analysis of hepatocellular carcinoma screening in high risk populations
    Chengdian Lan, Dan-Lan Lian, Cui-Ling Huang · 2026 · Discover Oncology
  23. The Promise of Machine Learning–Based Population Screening for Hepatocellular Carcinoma
    Zachariah H. Foda · 2026 · Cancer Discovery
  24. Hepatocellular carcinoma ultrasound surveillance adherence and outcomes in the UK: a multicentre retrospective service evaluation
    Edward Wigmore, Nagushan Abimanue, Tom Parry, Aiman Aslam, Jake E. Cowen, Anmol Gangi, Aloysious Dominic Aravinthan, James M Franklin · 2026 · Frontline Gastroenterology
  25. Proportion of time covered determines real-world hepatocellular carcinoma surveillance adherence and is associated with curative treatment: a single-centre retrospective deep dive
    Christopher Mysko, Azita Rajai, Kevin Kuriakose, Darren Griffiths, Stephanie Landi, Huw Purssell, Oliver Street, Deepankar Gahloth, A J Allen, Katherine Siaoa et al. · 2026 · Frontline Gastroenterology
  26. Patient experiences, understanding of and barriers to hepatocellular carcinoma ultrasound surveillance: a multicentre United Kingdom (UK) survey
    Aiman Aslam, J. Wong, Jonathan IF Jackson, Jason Kei Chak Mak, Michelle Dinsey, Ruth Reeve, Anmol Gangi, Aloysious Dominic Aravinthan, James M Franklin, Bushra Ali et al. · 2026 · Clinical Radiology
  27. Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta‐Analysis
    C. K. Wallace, Devin Razavi‐Shearer, Samantha Hall, Tarik Asselah, Cary James, Loreta Anesti Kondili, Shyam Kottilil, Daniel Low‐Beer, Poonam Mathur, Junko Tanaka et al. · 2026 · Journal of Viral Hepatitis
  28. Performance of ASAP, LG2m, and GP73 for HCC Detection in Patients with Cirrhosis
    Mohammad Jarrah, Mohammed Al-Hasan, Mariadelcarmen Yanez, Maria V. Yow, Eunice Amador, Diya Kar, Fouzia Ahmed, Nicole E. Rich, S Deodhar, Jenna Bedrava et al. · 2026 · Cancers
  29. Artificial intelligence in hepatocellular carcinoma diagnosis and AI-assisted treatment support: Current landscape and future directions
    Quan-Kai Lei, Tong-Xv Wu, Chu-Long Zhang, Yun‐Wen Zheng · 2026 · Liver Research
  30. Multi-Target HCC Blood Test Demonstrates Consistent Performance Across Subgroups of Patients with Chronic Liver Disease
    Amit G. Singal, Mark Camardo, Janelle J. Bruinsma, Elle Kielar‐Grevstad, Naga Chalasani, Binu V. John · 2026 · Cancers
  31. MRI of Hepatocellular Carcinoma: Cross-regional Perspectives on Trends and Opportunities
    Cher Heng Tan, Hanyu Jiang, Yuancheng Wang, Hsien Min Low, Christopher L. Welle, Shuwei Zhou, Giuseppe Brancatelli, Sudhakar Kundapur Venkatesh, Jeong Min Lee · 2026 · Radiographics
  32. Surveillance for Hepatocellular Carcinoma in Patients at High Risk
    Kathryn Jane Fowler, Aya Kamaya, Shuchi K. Rodgers, Danielle E. Kruse, Mustafa Rifaat Bashir, Guruveer S. Bhamra, Eun Sun Choi, Ahmed El Kaffas, Amit G. Singal, Hyo Jung Park et al. · 2026 · Radiographics
  33. Inequalities in hepatocellular carcinoma (HCC) surveillance uptake in London: a UK multicentre cohort study
    Maria Qurashi, Varsha Chaitanya-Bhide, Shahid Ahmed Khan, Nina Stafford, Jayshri Shah, Luke David Tyson, Zinu Philipose, Hooshang Izadi, Rohini Sharma · 2026 · BMJ Public Health